The United Laboratories International Holdings(HK:3933)
HK$7.49-0.24 (-3.11%)
HK:3933
The United Laboratories International Holdings financials statements
HK$7.49
At close:-0.24 (-3.11%)
Want to see HK:3933 full AI Analyst Report?
The United Laboratories International Holdings (3933) Income Statement
7 Followers
The United Laboratories International Holdings Income Statement
Last quarter (Q2 2026), The United Laboratories International Holdings's total revenue was ¥6.17B, a decrease of 14.07% from the same quarter last year. In Q2, The United Laboratories International Holdings's net income was ¥347.64M. See The United Laboratories International Holdings’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 13.21B | ¥ 13.76B | ¥ 13.74B | ¥ 11.33B | ¥ 9.70B | |
| ¥ 5.51B | ¥ 6.08B | ¥ 6.33B | ¥ 4.97B | ¥ 4.21B | |
| ¥ 3.24B | ¥ 3.23B | ¥ 3.05B | ¥ 2.95B | ¥ 2.80B | |
| Depreciation and Amortization | ¥ 649.54M | ¥ 615.55M | ¥ 565.65M | ¥ 552.43M | ¥ 620.86M |
| ¥ 2.87B | ¥ 3.43B | ¥ 3.98B | ¥ 2.57B | ¥ 2.00B | |
| ¥ 2.27B | ¥ 3.12B | ¥ 3.29B | ¥ 2.02B | ¥ 1.41B | |
| ¥ 256.17M | ¥ 172.58M | ¥ 54.83M | ¥ -18.31M | ¥ -208.75M | |
| ¥ 2.53B | ¥ 3.29B | ¥ 3.34B | ¥ 2.01B | ¥ 1.20B | |
| ¥ 2.09B | ¥ 2.66B | ¥ 2.70B | ¥ 1.58B | ¥ 988.10M | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 1.11 | ¥ 1.46 | ¥ 1.49 | ¥ 0.87 | ¥ 0.54 |
| Diluted EPS | ¥ 1.11 | ¥ 1.46 | ¥ 1.49 | ¥ 0.87 | ¥ 0.54 |
| Weighted Average Shares Outstanding | 1.89B | 1.82B | 1.82B | 1.82B | 1.84B |
| Weighted Average Shares Outstanding (Diluted) | 1.89B | 1.82B | 1.82B | 1.82B | 1.84B |
Currency in CNY

